- Investing Ideas
- /
- Telecom Healthcare Sector
Telecom Healthcare Sector
Results
2308
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,308 companies
Kun Peng International
Market Cap: US$26.0m
Engages in the distribution of health care and health-related household products through its online platforms in the People’s Republic of China.
KPEA
US$0.065
7D
-34.9%
1Y
-44.5%
Cyclacel Pharmaceuticals
Market Cap: US$25.9m
A clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, epigenetics, and mitosis biology in the United States and the United Kingdom.
CYCC
US$2.00
7D
-44.3%
1Y
-94.3%
Chemomab Therapeutics
Market Cap: US$25.8m
A clinical-stage biotechnology company, focuses on the discovery and development of therapeutics for the treatment of fibrotic and inflammatory diseases in the United States.
CMMB
US$1.37
7D
10.5%
1Y
59.3%
Micro-X
Market Cap: AU$40.0m
Designs, develops, manufactures, and commercializes healthcare and security markets products using micro-X proprietary cold cathode X-ray technology in Australia, the United States, Asia-Pacific, Europe, the Middle East, and Africa.
MX1
AU$0.06
7D
-6.3%
1Y
-31.0%
CytoMed Therapeutics
Market Cap: US$25.8m
A pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers and degenerative diseases in Malaysia and Singapore.
GDTC
US$2.24
7D
-2.0%
1Y
10.1%
One Health Group
Market Cap: UK£19.3m
Provides diagnosis and treatment for orthopedics, spine, general surgery, and gynecology patients.
OHGR
UK£1.83
7D
-0.3%
1Y
-1.4%
Daré Bioscience
Market Cap: US$25.6m
A biopharmaceutical company, develops therapies in the areas of contraception, reproductive health, menopause, fertility, and sexual and vaginal health in the United States.
DARE
US$2.89
7D
0.3%
1Y
-60.5%
Generation Bio
Market Cap: US$25.6m
A biotechnology company, discovers, develops, and commercializes redosable therapeutics that reprogram T cells in vivo to reduce or eliminate the production and persistence of autoreactive T cells.
GBIO
US$0.38
7D
-2.3%
1Y
-89.2%
INOVIQ
Market Cap: AU$39.6m
Engages in the developing and commercializing of diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States.
IIQ
AU$0.35
7D
-6.6%
1Y
-27.6%
Eagle Pharmaceuticals
Market Cap: US$25.3m
A pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States.
EGRX
US$1.94
7D
-2.5%
1Y
-57.9%
Prescient Therapeutics
Market Cap: AU$37.9m
A clinical stage oncology company, develops drugs for the treatment of various cancers in Australia.
PTX
AU$0.047
7D
-7.8%
1Y
0%
MIRA Pharmaceuticals
Market Cap: US$24.4m
Operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders.
MIRA
US$1.45
7D
18.9%
1Y
70.6%
Island Pharmaceuticals
Market Cap: AU$37.8m
A drug research and repurposing company, focuses on the development of preventative or therapeutic drugs for viral infections in Australia and the United States of America.
ILA
AU$0.18
7D
-2.7%
1Y
176.9%
23andMe Holding
Market Cap: US$24.1m
Operates as a consumer genetics testing company in the United States, the United Kingdom, Canada, and internationally.
MEHC.Q
US$0.90
7D
63.6%
1Y
-91.8%
iAnthus Capital Holdings
Market Cap: CA$33.7m
Owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States.
IAN
CA$0.005
7D
0%
1Y
-80.0%
Thiogenesis Therapeutics
Market Cap: CA$33.7m
A biopharmaceutical company, develops thiol-active therapeutic compounds to treat unmet pediatric medical needs.
TTI
CA$0.74
7D
13.8%
1Y
5.7%
Rubicon Organics
Market Cap: CA$33.6m
Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.
ROMJ
CA$0.43
7D
0%
1Y
8.8%
Tempest Therapeutics
Market Cap: US$24.0m
A clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer.
TPST
US$6.85
7D
-0.3%
1Y
-83.9%
OptiBiotix Health
Market Cap: UK£17.9m
A life sciences company, engages in the discovery and development of microbiome modulators in the United Kingdom, the United States, China, and internationally.
OPTI
UK£0.18
7D
-1.4%
1Y
0.7%
Enlivex Therapeutics
Market Cap: US$23.8m
Operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel.
ENLV
US$1.00
7D
-0.3%
1Y
-29.6%
IGC Pharma
Market Cap: US$23.8m
A clinical stage pharmaceutical company, engages in developing treatments for Alzheimer’s disease.
IGC
US$0.30
7D
-1.5%
1Y
-44.5%
Cryosite
Market Cap: AU$37.1m
Provides outsourced clinical trials logistic services in Australia.
CTE
AU$0.76
7D
6.3%
1Y
-10.6%
ABVC BioPharma
Market Cap: US$23.7m
A clinical-stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States.
ABVC
US$1.48
7D
8.8%
1Y
37.0%
Starpharma Holdings
Market Cap: AU$36.8m
A biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications worldwide.
SPL
AU$0.088
7D
-2.2%
1Y
-23.5%
Vaso
Market Cap: US$23.7m
Operates in the healthcare equipment and information technology industries in the United States and internationally.
VASO
US$0.13
7D
2.2%
1Y
-43.3%
KALA BIO
Market Cap: US$23.7m
A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of therapies for rare and severe eye diseases.
KALA
US$3.67
7D
4.9%
1Y
-44.6%
Pulmatrix
Market Cap: US$23.7m
A clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States.
PULM
US$6.48
7D
3.8%
1Y
228.9%
Inspiration Healthcare Group
Market Cap: UK£17.7m
Designs, manufactures, and sells medical technology products worldwide.
IHC
UK£0.20
7D
14.5%
1Y
21.5%
Doctor Care Anywhere Group
Market Cap: AU$36.7m
Provides digital healthcare and development services in the United Kingdom and the Republic of Ireland.
DOC
AU$0.10
7D
14.9%
1Y
53.8%
FLUENT
Market Cap: US$23.6m
Through its subsidiaries, cultivates, manufactures processes, distributes, and sells medical cannabis products for medical and adult-use markets in Florida, New York, Pennsylvania, and Texas.
FNT.U
US$0.05
7D
0%
1Y
-72.2%
BioAtla
Market Cap: US$23.4m
A clinical-stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer.
BCAB
US$0.40
7D
-7.4%
1Y
-83.7%
ALX Oncology Holdings
Market Cap: US$23.4m
A clinical-stage immuno-oncology company, focuses on developing therapies for cancer patients in the United States.
ALXO
US$0.44
7D
0.5%
1Y
-96.8%
Clene
Market Cap: US$23.1m
A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics.
CLNN
US$2.57
7D
-5.5%
1Y
-65.5%
Nova Eye Medical
Market Cap: AU$35.5m
Designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally.
EYE
AU$0.13
7D
0%
1Y
-57.6%
Avicanna
Market Cap: CA$31.9m
A commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for consumer, medical, and pharmaceutical markets worldwide.
AVCN
CA$0.28
7D
14.0%
1Y
-20.8%
Grey Wolf Animal Health
Market Cap: CA$31.8m
Operates as an animal health and wellness company in Canada.
WOLF
CA$0.93
7D
3.3%
1Y
14.8%